Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients

BACKGROUND: Immunotherapy for patients with microsatellite‐instable (MSI‐H) tumors or BRAF‐inhibitors combination treatment for BRAF‐mutated (mutBRAF) tumors in metastatic colorectal cancer (mCRC) is promising, but the frequency of these molecular changes in trial patients are low. Unselected popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Aasebø, Kristine Ø., Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per‐Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601706/
https://www.ncbi.nlm.nih.gov/pubmed/31070306
http://dx.doi.org/10.1002/cam4.2205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601706/
https://www.ncbi.nlm.nih.gov/pubmed/31070306
http://dx.doi.org/10.1002/cam4.2205

Ejemplares similares